Topics in Lung Disease: Pulmonary Hypertension

Area of Science:

• Cardiology
• Pulmonology
• Internal Medicine

Background:

• Pulmonary hypertension (PH) is a progressive disorder marked by high pulmonary artery pressure.
• Early diagnosis relies on recognizing symptoms like dyspnea and fatigue, with echocardiography as a primary tool.

Purpose of the Study:

• To outline diagnostic criteria for PH, including echocardiography and right heart catheterization.
• To detail primary and secondary prevention strategies for PH.
• To review current and emerging pharmacotherapies for pulmonary arterial hypertension (PAH).

Main Methods:

• Diagnosis confirmed by right heart catheterization (mean pulmonary artery pressure ≥20 mm Hg, pulmonary vascular resistance >2 Wood units).
• Prevention strategies encompass lifestyle modifications, risk factor control (hypertension, diabetes), and environmental exposure management.
• Pharmacotherapy review includes targeting endothelin, prostacyclin, and nitric oxide pathways.

Main Results:

• Advances in pharmacotherapy targeting specific pathways have enhanced outcomes for pulmonary arterial hypertension.
• Combination therapy is advised for moderate-to-severe disease; parenteral prostanoids are for advanced PAH.
• Management of right-sided heart failure involves fluid management, diuretics, and consideration of lung transplantation or palliative procedures.

Conclusions:

• Effective management of pulmonary hypertension requires early suspicion, accurate diagnosis, and comprehensive prevention strategies.
• Novel pharmacotherapies offer improved outcomes, with combination therapy and advanced treatments tailored to disease severity.
• Integrated supportive care, including nutrition and management of complications like right-sided heart failure, is crucial for PH patients.